Abstract
Cardiopulmonary and renal end organ (CPR) complications are associated with early mortality among individuals with sickle cell disease (SCD). However, there is limited knowledge regarding acute care utilization for individuals with SCD and CPR complications. Our objective was to determine the prevalence of CPR complications in a state specific SCD population and compare acute care utilization among individuals with and without CPR complications. We leveraged 2017–2020 data for individuals with SCD identified by the Sickle Cell Data Collection program in Wisconsin. The prevalence of CPR complications is determined for distinct age groups. Generalized linear models adjusted for age compared the rate of acute care visits/person/year among individuals who had cardiopulmonary only, renal only, both cardiopulmonary and renal, or no CPR complications. There were 1378 individuals with SCD, 52% females, mean (SD) age 28.3 (18.5) years; 48% had at least one CPR complication during the study period. The prevalence of CPR complications was higher in adults (69%) compared to pediatric (15%) and transition (51%) groups. Individuals with SCD and cardiopulmonary complications had higher acute visit rates than those without CPR complications (5.4 (IQR 5.0–5.8) vs 2.4 (IQR 2.1–2.5), p <0.001)). Acute care visit rates were similar between individuals with SCD who had renal only complications and no CPR complications (2.7 (IQR 2.5–3.0) vs 2.4 (2.1–2.5), p = 0.24). The high acute care visit rates, especially for those with cardiopulmonary complications, warrant further investigation to understand risk factors for CPR complications, the underlying reasons and identify effective disease management strategies.
Funder
Centers for Disease Control and Prevention
Publisher
Public Library of Science (PLoS)
Reference24 articles.
1. Sickle-cell disease;DC Rees;The Lancet,2010
2. National Center on Birth Defects and Developmental Disabilities CfDCaP. Complications of sickle cell disease. https://www.cdc.gov/ncbddd/sicklecell/complications.html. Published 2022. Accessed 10/07/2022.
3. All-Cause Mortality and Incidence of Major Adverse Cardiac Events in Sickle Cell Nephropathy: A Comparative Study.;K Udani;Cureus,2021
4. Cardiovascular complications in patients with sickle cell disease;MT Gladwin;Hematology Am Soc Hematol Educ Program,2017
5. A phenotypic risk score for predicting mortality in sickle cell disease;V Sachdev;British Journal of Haematology,2021